SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-044885
Filing Date
2023-08-29
Accepted
2023-08-29 07:03:40
Documents
13
Period of Report
2023-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K omga-20230826.htm   iXBRL 8-K 72976
  Complete submission text file 0000950170-23-044885.txt   224089

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20230826.xsd EX-101.SCH 2914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20230826_lab.xml EX-101.LAB 17468
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20230826_pre.xml EX-101.PRE 14464
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT omga-20230826_def.xml EX-101.DEF 14386
7 EXTRACTED XBRL INSTANCE DOCUMENT omga-20230826_htm.xml XML 4884
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40657 | Film No.: 231218037
SIC: 2836 Biological Products, (No Diagnostic Substances)